Pregnancy
  • 7-510: A Review of Nutritional Recommendations for Pregnant Women Living with HIV

    A Review of Nutritional Recommendations for Pregnant Women Living with HIV

    Report, 2012


    Ensuring proper nutrition is a critical component of living with HIV as it is with being pregnant. The two conditions combined mean that pregnant women living with HIV are especially vulnerable to nutrient deficiencies and these women must monitor their nutritional status accordingly. The review provides general recommendations to address these issues.

    Report, 2012


    Ensuring proper nutrition is a critical component of living with HIV as it is with being pregnant. The two conditions combined mean that pregnant women living with HIV are especially vulnerable to nutrient deficiencies and these women must monitor their nutritional status accordingly. The review provides general recommendations to address these issues.



    SKU: 7-510
  • Adolescent Pregnancy in Saskatchewan

    Adolescent Pregnancy in Saskatchewan

    Report, 2014


    In Canada, rates of adolescent pregnancy remain among the highest in developed countries and rates in Saskatchewan are among the highest in Canada. In an effort to address the needs of Saskatchewan youth, the Saskatchewan Prevention Institute has developed this report to provide a picture of adolescent pregnancy in Saskatchewan and to identify best practices that my address the specific circumstances of Saskatchewan Youth.

    Report, 2014


    In Canada, rates of adolescent pregnancy remain among the highest in developed countries and rates in Saskatchewan are among the highest in Canada. In an effort to address the needs of Saskatchewan youth, the Saskatchewan Prevention Institute has developed this report to provide a picture of adolescent pregnancy in Saskatchewan and to identify best practices that my address the specific circumstances of Saskatchewan Youth.



    SKU: 7-018
  • 4-309: Before You Become Pregnant

    Before You Become Pregnant

    Brochure, Revised 2022


    This brochure talks about the important information a woman should know when planning a pregnancy. It promotes a healthy lifestyle prior to conception in order to ensure the healthiest baby possible.

    Brochure, Revised 2022


    This brochure talks about the important information a woman should know when planning a pregnancy. It promotes a healthy lifestyle prior to conception in order to ensure the healthiest baby possible.

    or
    SKU: 2-309
  • 2-461: Cannabis and Pregnancy Poster

    Cannabis and Pregnancy Poster

    Poster, 2019


    Cannabis can be harmful. This poster highlights that cannabis can harm developing fetuses during pregnancy, and infants through breastfeeding. This poster was created in partnership with the Cannabinoid Research Institute of Saskatchewan.

    Poster, 2019


    Cannabis can be harmful. This poster highlights that cannabis can harm developing fetuses during pregnancy, and infants through breastfeeding. This poster was created in partnership with the Cannabinoid Research Institute of Saskatchewan.

    or
    SKU: 2-461
  • 2-106: Cannabis Use in the Childbearing Years: An Evidence Summary for Healthcare Providers

    Cannabis Use in the Childbearing Years: An Evidence Summary for Healthcare Providers

    Report, 2018


    Due to the legalization of cannabis in Canada, and for the health of children and families, there is a growing need to provide parents, prospective parents, healthcare professionals, and other service providers with evidence-based information about the potential risks of cannabis use. This evidence summary is for healthcare providers. It provides general information about cannabis and rates of cannabis use in Canada, as well as information about the potential risks of cannabis use before, during, and after pregnancy. This summary also offers several recommendations for public messaging based on the available research.

    Report, 2018


    Due to the legalization of cannabis in Canada, and for the health of children and families, there is a growing need to provide parents, prospective parents, healthcare professionals, and other service providers with evidence-based information about the potential risks of cannabis use. This evidence summary is for healthcare providers. It provides general information about cannabis and rates of cannabis use in Canada, as well as information about the potential risks of cannabis use before, during, and after pregnancy. This summary also offers several recommendations for public messaging based on the available research.



    SKU: 2-106
  • 2-251: Common Non-prescription Medications in Pregnancy

    Common Non-prescription Medications in Pregnancy

    Fact Sheet, Revised 2021


    Non-prescription medications, sometimes referred to as over-the-counter or OTC medications, are those that can be purchased without having a doctor’s prescription. This fact sheet provides information on common OTC medications such as antacids, antihistamines, laxatives, cough and cold medications, herbal products, and many more that are used in pregnancy.

    Fact Sheet, Revised 2021


    Non-prescription medications, sometimes referred to as over-the-counter or OTC medications, are those that can be purchased without having a doctor’s prescription. This fact sheet provides information on common OTC medications such as antacids, antihistamines, laxatives, cough and cold medications, herbal products, and many more that are used in pregnancy.



    SKU: 2-251
  • EPDS Screening and Care Guide

    Edinburgh Postpartum Depression Scale (EPDS) Screening and Care Guide

    Guide and Manual, 2012


    The EPDS Screening and Care Guide provides healthcare providers with score interpretation and care guide to use when screening pregnant and postpartum women for depression and anxiety using the Edinburgh Postpartum Depression Scale (EPDS). It also includes guidelines for medical management when maternal mental health is of concern, contact information for Saskatchewan Healthline and Saskatchewan Drug Information Services, and a space for relevant local contact information. On the reverse side of the form there is a brief description of maternal depression including common symptoms, guidelines for screening, and the EPDS questions.

    * For an updated version of the Maternal Mental Health Edinburgh Postnatal Depression Scale (EPDS) Screening and Care Guide available through the Saskatchewan Ministry of Health, please visit https://www.ehealthsask.ca/services/resources/Resources/EPDS-screening-2019.pdf

    Guide and Manual, 2012


    The EPDS Screening and Care Guide provides healthcare providers with score interpretation and care guide to use when screening pregnant and postpartum women for depression and anxiety using the Edinburgh Postpartum Depression Scale (EPDS). It also includes guidelines for medical management when maternal mental health is of concern, contact information for Saskatchewan Healthline and Saskatchewan Drug Information Services, and a space for relevant local contact information. On the reverse side of the form there is a brief description of maternal depression including common symptoms, guidelines for screening, and the EPDS questions.

    * For an updated version of the Maternal Mental Health Edinburgh Postnatal Depression Scale (EPDS) Screening and Care Guide available through the Saskatchewan Ministry of Health, please visit https://www.ehealthsask.ca/services/resources/Resources/EPDS-screening-2019.pdf


    SKU: 2-104
  • Fetal Development

    Fetal Development

    Poster, 2008


    These 8.5 x 11 inch posters, developed by Childbirth Graphics, assist healthcare professionals in discussing alcohol use with their patients. Although these posters do not focus on FASD, they can be used to help patients understand that alcohol is one of many factors which can impact the development of the fetus.

    Audience: Healthcare Professionals and their Patients

    Poster, 2008


    These 8.5 x 11 inch posters, developed by Childbirth Graphics, assist healthcare professionals in discussing alcohol use with their patients. Although these posters do not focus on FASD, they can be used to help patients understand that alcohol is one of many factors which can impact the development of the fetus.

    Audience: Healthcare Professionals and their Patients
    SKU: 3-143
  • Folic Acid and the Prevention of Neural Tube Defects

    Folic Acid and the Prevention of Neural Tube Defects

    Fact Sheet, 2016


    Provides information on neural tube defects and the importance of taking folic acid before becoming pregnant.

    Fact Sheet, 2016


    Provides information on neural tube defects and the importance of taking folic acid before becoming pregnant.



    SKU: 2-301
  • 2-502: Gestational Diabetes - What You Need to Know

    Gestational Diabetes – What You Need to Know

    Brochure, 2022


    Gestational diabetes, also known as gestational diabetes mellitus (GDM), is a type of diabetes that begins in pregnancy. This brochure provides information on the risk factors for developing GDM, its impact on the mother and the baby, screening, management, and prevention of GDM, as well as supports available to people with GDM in Saskatchewan.

    Brochure, 2022


    Gestational diabetes, also known as gestational diabetes mellitus (GDM), is a type of diabetes that begins in pregnancy. This brochure provides information on the risk factors for developing GDM, its impact on the mother and the baby, screening, management, and prevention of GDM, as well as supports available to people with GDM in Saskatchewan.

    or
    SKU: 2-502
  • 2-442: Gestational Diabetes Fact Sheet

    Gestational Diabetes Fact Sheet

    Fact Sheet, 2020


    Gestational diabetes, also known as gestational diabetes mellitus (GDM), is a sub-type of diabetes that is first identified during pregnancy. This fact sheet provides information on risk factors for developing GDM, its impact on maternal and child health, screening and diagnosis, as well as recommended management and primary prevention strategies.

    Fact Sheet, 2020


    Gestational diabetes, also known as gestational diabetes mellitus (GDM), is a sub-type of diabetes that is first identified during pregnancy. This fact sheet provides information on risk factors for developing GDM, its impact on maternal and child health, screening and diagnosis, as well as recommended management and primary prevention strategies.



    SKU: 2-442
  • 2-448: Gestational Diabetes Risks Prevention and Treatments

    Gestational Diabetes Risks Prevention and Treatments

    Literature Review, 2020


    Gestational diabetes, also known as gestational diabetes mellitus (GDM), is a sub-type of diabetes that is first identified during pregnancy. It consists of abnormal glucose tolerance or higher than normal blood glucose levels, that may or may not diminish following the birth of an infant. Over the past decades, GDM rates have continued to increase in Canada. This review provides information on the risk factors for developing GDM, its impact on maternal and offspring health, the approach to screening and diagnosis, recommended management strategies (both pharmacological and non-pharmacological), as well as primary prevention strategies.

    Literature Review, 2020


    Gestational diabetes, also known as gestational diabetes mellitus (GDM), is a sub-type of diabetes that is first identified during pregnancy. It consists of abnormal glucose tolerance or higher than normal blood glucose levels, that may or may not diminish following the birth of an infant. Over the past decades, GDM rates have continued to increase in Canada. This review provides information on the risk factors for developing GDM, its impact on maternal and offspring health, the approach to screening and diagnosis, recommended management strategies (both pharmacological and non-pharmacological), as well as primary prevention strategies.



    SKU: 2-448
  • GPC Evidence Summary

    GPC Evidence Summary

    Report, 2016


    Group prenatal care is a model of group where eight to twelve women of similar gestational age meet as a group with their healthcare provider for 90-120 minutes of regularly scheduled appointments, starting in their second trimester and continuing throughout their pregnancy. During these appointments, each woman has a brief individual physical assessment with the healthcare provider and then participates in a group discussion led by a healthcare provider. All prenatal care is provided in this group setting, combining the usual physical assessment with peer support and increased time for education about healthy pregnancy. This report examines current research on group prenatal care to assess if it is a good model of care for Saskatchewan and if there is an improvement in birth outcomes and breastfeeding rates associated with using this model of care compared to individual prenatal care. Birth outcomes examined in this report are gestational age at birth, preterm birth, and low birth weight.

    Report, 2016


    Group prenatal care is a model of group where eight to twelve women of similar gestational age meet as a group with their healthcare provider for 90-120 minutes of regularly scheduled appointments, starting in their second trimester and continuing throughout their pregnancy. During these appointments, each woman has a brief individual physical assessment with the healthcare provider and then participates in a group discussion led by a healthcare provider. All prenatal care is provided in this group setting, combining the usual physical assessment with peer support and increased time for education about healthy pregnancy. This report examines current research on group prenatal care to assess if it is a good model of care for Saskatchewan and if there is an improvement in birth outcomes and breastfeeding rates associated with using this model of care compared to individual prenatal care. Birth outcomes examined in this report are gestational age at birth, preterm birth, and low birth weight.



    SKU: 2-904
  • Group Prenatal Care Lit Review

    Group Prenatal Care Lit Review

    Report, 2016


    Group prenatal care is a model of group where eight to twelve women of similar gestational age meet as a group with their healthcare provider for 90-120 minutes of regularly scheduled appointments, starting in their second trimester and continuing throughout their pregnancy. During these appointments, each woman has a brief individual physical assessment with the healthcare provider and then participates in a group discussion led by a healthcare provider. All prenatal care is provided in this group setting, combining the usual physical assessment with peer support and increased time for education about healthy pregnancy. This report examines current research on group prenatal care to assess if it is a good model of care for Saskatchewan and if there is an improvement in birth outcomes and breastfeeding rates associated with using this model of care compared to individual prenatal care. Birth outcomes examined in this report are gestational age at birth, preterm birth, and low birth weight.

    Report, 2016


    Group prenatal care is a model of group where eight to twelve women of similar gestational age meet as a group with their healthcare provider for 90-120 minutes of regularly scheduled appointments, starting in their second trimester and continuing throughout their pregnancy. During these appointments, each woman has a brief individual physical assessment with the healthcare provider and then participates in a group discussion led by a healthcare provider. All prenatal care is provided in this group setting, combining the usual physical assessment with peer support and increased time for education about healthy pregnancy. This report examines current research on group prenatal care to assess if it is a good model of care for Saskatchewan and if there is an improvement in birth outcomes and breastfeeding rates associated with using this model of care compared to individual prenatal care. Birth outcomes examined in this report are gestational age at birth, preterm birth, and low birth weight.



    SKU: 2-903
  • 7-500: HCV and Pregnancy Fact Sheet

    HCV and Pregnancy Fact Sheet

    Fact Sheet, 2020


    This fact sheet provides information about hepatitis C (HCV) and pregnancy, including information about vertical transmission (from mother to baby) and the effects of HCV on pregnancy and infants.

    Fact Sheet, 2020


    This fact sheet provides information about hepatitis C (HCV) and pregnancy, including information about vertical transmission (from mother to baby) and the effects of HCV on pregnancy and infants.



    SKU: 7-500